|Chemical and physical data|
|Molar mass||423.350 g·mol−1|
Estrobin, also known as α,α-di(p-ethoxyphenyl)-β-phenylbromoethylene and commonly abbreviated as DBE, is a synthetic, nonsteroidal estrogen of the triphenylethylene group that was never marketed. Chlorotrianisene, and subsequently clomifene and tamoxifen, were derived from it. Estrobin, similarly to other triphenylethylenes, is very lipophilic and hence very long-lasting in its duration of action. Similarly to chlorotrianisene, estrobin behaves a prodrug to a much more potent estrogen in the body.
- Virgil Craig Jordan (1986). Estrogen/antiestrogen Action and Breast Cancer Therapy. Univ of Wisconsin Press. pp. 23–. ISBN 978-0-299-10480-1.
- Welsh, Ashton L. (1954). "USE OF SYNTHETIC ESTROGENIC SUBSTANCE CHLOROTRIANISENE (TACE) IN TREATMENT OF ACNE". Archives of Dermatology. 69 (4): 418. doi:10.1001/archderm.1954.01540160020004. ISSN 0003-987X.
|This drug article relating to the genito-urinary system is a stub. You can help Wikipedia by expanding it.|